Cardium Reports On Advancement Of Generx And Excellagen Biologic Products And Corporate Developments

Clinical and Preclinical Results Have Implications for Use of Generx as a Non-Surgical Gene Therapy for Coronary Artery Disease, and Excellagen to Potentiate Stem Cell Therapies /PRNewswire/ -- Cardium Therapeutics today reported on advancements of the Company's two key biologics products, its GenerxA candidate for the potential treatment of ... (more)

http://www.sys-con.com/node/2911418